Skip to main content
OpenTrials
Completed

NCT Number: NCT04912934

The Relationship Between COVID-19 Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome

The aim was to determine the coronavirus anxiety levels and emotional eating status of cases with diagnosis of MetS according to diagnostic criteria published by the International Diabetic Federation (IDF) in 2005 and healthy individuals with similar BMI to MetS subjects.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The aim was to determine the coronavirus anxiety levels and emotional eating status of cases with diagnosis of MetS according to diagnostic criteria published by the International Diabetic Federation (IDF) in 2005 and healthy individuals with similar BMI to MetS subjects. This study was completed with the descriptive, cross-sectional and relational screening model. The full sampling method was used in the study. The study was completed with 105 individuals with metabolic syndrome attending the diet clinic and 109 healthy individuals without MetS diagnosis also attending the diet clinic. Collection of data used anthropometric measurements and biochemical findings, blood pressure and a survey form, the Coronavirus Anxiety Scale (CAS) and Emotional Eating Scale (EES).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The research included individuals aged 18 years and older, who were not pregnant or breastfeeding, without any psychological disorder diagnosed by psychiatry, without diagnosis of COVID-19 and not using any psychiatric medications. The MetS group for the research included individuals with metabolic syndrome diagnosis according to IDF-2005 diagnostic criteria. The non MetS group in the research included healthy individuals not using any psychiatric medications, without any chronic disorder, and with similar BMI to the individuals in the subject group.

Exclusion criteria

  • The research included individuals aged 18 years and older, who were pregnant or breastfeeding, with psychological disorder diagnosed by psychiatry, with diagnosis of COVID-19 and using psychiatric medications.

Treatment and study plan

A survey form was applied to individuals included in the study face-to-face.

Procedure

This study was completed with a descriptive, cross-sectional and relational screening model

Other names: This survey form, Biochemical findings (glucose, HDL, LDL, total cholesterol, triglycerides, CRP, HbA1c, insulin, HOMA-IR)., Blood pressure was measured and recorded., The coronavirus anxiety scale (CAS) and emotional eating scale (EES) were applied.

Primary outcomes

  1. Coronavirus anxiety scale (CAS)

    Time frame: 5 month

    Total points of ≥9 on the scale shows dysfunctional anxiety related to coronavirus.

  2. Emotional eating scale (EES)

    Time frame: 5 month.

    High points on the scale show high levels of emotional eating behavior.

Secondary outcomes

  1. BMI (Body Mass Index)

    Time frame: 5 month.

    kg/m^2

  2. Glucose

    Time frame: 5 month.

    mg/dL

  3. Blood pressure

    Time frame: 5 month.

    Systolic and diastolic blood pressure

  4. HDL

    Time frame: 5 month.

    mg/dL

  5. LDL

    Time frame: 5 month.

    mg/dL

  6. triglycerides

    Time frame: 5 month.

    mg/dL

  7. HbA1c

    Time frame: 5 month.

    HbA1c (%)

  8. insulin

    Time frame: 5 month.

    ng/ml

  9. HOMA-IR

    Time frame: 5 month.

    index

  10. total cholesterol

    Time frame: Through study completion, an average of 5 month.

    mg/dL

  11. CRP

    Time frame: 5 month.

    mg/dL

Sponsors and collaborators

Lead sponsor

Ordu University

Other

Registry information

Official study title

The Relationship Between Coronavirus Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome

Acronym: COVID-19

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jun 3, 2021
Registry last updated
Jun 3, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.